ClinicalTrials.Veeva

Menu

ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease

A

Aalborg University Hospital

Status

Begins enrollment this month

Conditions

Hashimoto's Thyroiditis
Hypothyroidism
Thyroid Disease
Hyperthyreosis and Goiter

Treatments

Other: Rhythm- and Multitask-Based Activity (RYMA) and Activities of Daily Living (ADL)

Study type

Interventional

Funder types

Other

Identifiers

NCT06960005
N-20240055

Details and patient eligibility

About

Objectives:

This study aims to assess health-related quality of life (QoL) in adults with thyroid hormone disorders and identify modifiable factors to improve QoL in patients with Hashimoto's thyroiditis (HT) and multinodular toxic goiter (MNTG) through an exercise intervention.

Primary Outcome:

  1. Assess the impact of a tailored exercise program on health-related QoL in patients with HT and MNTG using the ThyPRO questionnaire.

Secondary Outcomes:

  1. Evaluate the need for a screening tool to identify thyroid patients with reduced health-related QoL despite being euthyroid.
  2. Assess the impact of the exercise intervention on body composition, strength, and balance function in HT and MNTG patients.

Methods:

The study is a combined cross-sectional survey and randomized controlled trial into the health related QoL in patients diagnosed with thyroid hormone disease. The cross-sectional survey will assess the overall health-related QoL in patients diagnosed with thyroid hormone disease, and help identify eligible participants for the subsequent RCT.

The RCT will evaluate the efficacy of a comprehensive screening and exercise intervention in patients ≥ 65 years diagnosed with HT or MNTG, experiencing reduced health-related QoL.

Participants:

The aim is to recruit 74 patients with HT and 74 patients with MNTG, including 50 participants from each group with reduced health-related QoL (defined in this study as ThyPRO score ≥ 30) and 24 with good health-related QoL (ThyPRO score ≤ 20)

Enrollment

148 estimated patients

Sex

Female

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Women with minimum 65 years of age, with no upper limit.
  2. Verified diagnosis of HT or MNTG
  3. Euthyroid for at least 6 months
  4. Signed the informed consent

Exclusion criteria

  1. Current participation in a structured exercise program or regular physical exercise activity above 5 hours per week
  2. Previous experience with rhythm-based multitask exercise.
  3. Diagnosed with significant neurological diseases (e.g. Multiple Sclerosis and myasthenia gravis), vestibular diseases or newly orthopedic surgeries (e.g. knee or hip replacement)
  4. Fully dependent on walking aids
  5. Active malignancy or terminal illness
  6. Inability to understand Danish written and/or verbally
  7. Having severely impaired cognitive function, defined as a score below 8 on the cognitive assessment "the short orientation-memory-concentration test"
  8. Treatment with amiodarone within the last year
  9. No changes within the last six months in medications affecting weight or body composition - e.g., GLP-1 electrolyte/fluid balance - e.g., diuretics or corticosteroid
  10. Participation in other clinical intervention studies within the last six months

For the cross sectional survey:

Inclusion criteria:

  1. Men and women with a minimum of 18 years
  2. Diagnosis of primary hypothyroidism or primary hyperthyroidism

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

148 participants in 2 patient groups

Exercise intervention: RYMA
Experimental group
Description:
Participants in this arm will engage in the Rhythm- and Multitask-Based Activity (RYMA) program, a 26-week multicomponent exercise intervention designed to enhance quality of life, improve physical function, and prevent falls. The program integrates strength, balance, coordination, and cognitive-motor training, along with Activities of Daily Living (ADL)-based exercises to support real-world functionality.
Treatment:
Other: Rhythm- and Multitask-Based Activity (RYMA) and Activities of Daily Living (ADL)
Control group: Usual Care/No Structured Exercise Intervention
No Intervention group
Description:
Participants will be screened and followed but not participate in the exercise intervention and continue their usual activities.

Trial contacts and locations

1

Loading...

Central trial contact

Mia Daugaard Madsen, Medical Doctor; Peter Vestergaard, MD, PhD, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems